Humigent

Startup

Humigent builds AI-powered operational agents purpose-built for biopharma companies developing and commercializing rare disease therapies. From clinical-stage biotechs preparing for first launch to commercial teams scaling with lean resources, our platform is grounded in deep pharma domain knowledge — the workflows, regulatory constraints, and operational realities unique to rare and orphan disease markets. We also support the broader rare disease ecosystem, including specialty services, diagnostics, and patient support organizations.

Our agents are rules-grounded and constrained by design: outputs are predictable, reproducible, and tied to defined logic — not open-ended generation. Every action is auditable, every decision is traceable, and every workflow maintains a complete compliance log. Human-in-the-loop controls are embedded at every critical step, ensuring AI augments expert judgment rather than replacing it.

Rare disease biopharma teams face a unique challenge: small organizations navigating complex compliance environments, vast patient-finding geographies, specialty pharmacy coordination, and operational demands that rival large pharma, but with a fraction of the resources. Humigent gives these teams the leverage to do more with less across field operations, market access, patient services, and launch readiness.

Humigent: humans and agents, working together.

website